Safety Concerns and Reported Complications There have been growing reports of adverse reactions associated with compounded semaglutide, including unexpected gastrointestinal side effects, excessive nausea, severe dehydration, and symptoms not typically seen with FDA-approved GLP-1 medications
What the Research Found GLP-1 users showed an 18 percent lower risk of alcohol use disorder, a 20 percent lower risk of cocaine use disorder, and a 25 percent lower risk of opioid use disorder compared to the active comparator group
PRP delivers a concentrated burst of growth factors at the injection site, while BPC-157 sustains the angiogenic and healing environment that PRP initiates
You leave the consultation knowing exactly what is in your IV and why
Or you do the animal research or the cell research so that you can at least prove a mechanism and then either that becomes your explanatory devicewell, look, the mechanism works so it must explain what we see over here even though we don't have the five-year 100,000 person RCT to prove it